Volume | 230,094 |
|
|||||
News | - | ||||||
Day High | 218.025 | Low High |
|||||
Day Low | 208.01 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Karuna Therapeutics Inc | KRTX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
210.24 | 208.01 | 218.025 | 208.00 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
7,474 | 230,094 | US$ 214.20 | US$ 49,286,411 | - | 158.375 - 245.00 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:52:45 | 14 | US$ 210.39 | USD |
Karuna Therapeutics (KRTX) Options Flow Summary
Karuna Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
8B | 37.73M | - | 10.64M | -276.34M | -7.32 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Karuna Therapeutics News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KRTX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 186.73 | 218.025 | 185.84 | 198.00 | 281,106 | 23.55 | 12.61% |
1 Month | 180.00 | 218.025 | 162.46 | 185.83 | 230,431 | 30.28 | 16.82% |
3 Months | 185.50 | 218.025 | 158.375 | 176.33 | 248,767 | 24.78 | 13.36% |
6 Months | 234.36 | 245.00 | 158.375 | 197.10 | 301,038 | -24.08 | -10.27% |
1 Year | 217.13 | 245.00 | 158.375 | 196.17 | 329,717 | -6.85 | -3.15% |
3 Years | 100.93 | 278.2532 | 91.04 | 172.90 | 273,305 | 109.35 | 108.34% |
5 Years | 18.50 | 278.2532 | 11.24 | 141.08 | 283,540 | 191.78 | 1,036.65% |
Karuna Therapeutics Description
Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues. |